Literature DB >> 14708896

Ornidazole-induced liver damage: report of three cases and review of the literature.

Fehmi Tabak1, Resat Ozaras, Yusuf Erzin, Aykut Ferhat Celik, Gulsen Ozbay, Hakan Senturk.   

Abstract

Metronidazole and ornidazole, synthetic nitroimidazole derivatives, are used in the treatment of infections caused by anaerobic bacteria and protozoa. The drugs are well tolerated and serious side effects are very rarely encountered. Hepatotoxicity is a rare side effect and hitherto only six cases have been reported. We describe three patients who developed hepatitis after ornidazole use and review the previously reported cases. All three cases used ornidazole in conventional doses and developed hepatitis and associated cholestasis. They improved 1-2 months after discontinuation. We concluded that nitroimidazole derivatives may cause hepatotoxic damage resembling acute cholestatic hepatitis. Early recognition and withdrawal of the drug may prevent further damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708896     DOI: 10.1034/j.1478-3231.2003.00860.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  2 in total

Review 1.  Hepatic manifestations of non-steroidal inflammatory bowel disease therapy.

Authors:  Robert Hirten; Keith Sultan; Ashby Thomas; David E Bernstein
Journal:  World J Hepatol       Date:  2015-11-28

2.  Hepatic Failure following Metronidazole in Children with Cockayne Syndrome.

Authors:  Pedram Ataee; Avat Karimi; Kambiz Eftekhari
Journal:  Case Rep Pediatr       Date:  2020-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.